Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells

Blood

Volumn 117, Issue 17, 2011, Pages 4632-4641

  Chaurasia, Pratima ^a   Berenzon, Dmitriy ^a,b   Hoffman, Ronald ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLOBIN; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; RHESUS ANTIGEN; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD TRANSFUSION; CD34 SELECTION; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

EID: 79955967361     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-314567     Document Type: Article

References (45)

1. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. 1997; 90(12):4665-4678. (Pubitemid 28007178)
2. Neildez-Nguyen TM, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20(5):467-472. (Pubitemid 34495932)
3. Migliaccio G, Di Pietro R, di Giacomo V, et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28(2): 169-180. (Pubitemid 34743751)
4. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74. (Pubitemid 41724627)
5. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006; 24(10):1255-1256. (Pubitemid 44564771)
6. Matsunaga T, Tanaka I, Kobune M, et al. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells. 2006;24(12): 2877-2887. (Pubitemid 46053024)
7. Chang AH, Stephan MT, Sadelain M. Stem cell-derived erythroid cells mediate long-term systemic protein delivery. Nat Biotechnol. 2006; 24(8):1017-1021. (Pubitemid 44215396)
8. Douay L, Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion? Transfus Med Rev. 2007;21(2):91-100. (Pubitemid 46486703)
9. Dorn I, Lazar-Karsten P, Boie S, et al. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems. Transfusion. 2008;48(6):1122-1132. (Pubitemid 351793482)
10. Hiroyama T, Miharada K, Sudo K, Danjo I, Aoki N, Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One. 2008;3(2):e1544.
11. Fujimi A, Matsunaga T, Kobune M, et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol. 2008;87(4):339-350.
12. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol. 2009; 16(4):259-268.
13. Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science; 329(5997):1345-1348.
14. Lu SJ, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112(12):4475-4484.
15. Lapillonne H, Kobari L, Mazurier C, et al. Red blood cells generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010;95(10):1651-1659.
16. Bender JG, Unverzagt KL, Walker DE, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77(12):2591-2596.
17. Thoma SJ, Lamping CP, Ziegler BL. Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. Blood. 1994;83(8):2103-2114. (Pubitemid 24112721)
18. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137(1):20-35. (Pubitemid 46426403)
19. De Felice L, Tatarelli C, Mascolo MG, et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res. 2005;65(4): 1505-1513. (Pubitemid 40270180)
20. Zardo G, Cimino G, Nervi C. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. Leukemia. 2008;22(8):1503-1518.
21. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074-1080. (Pubitemid 32758077)
22. Milhem M, Mahmud N, Lavelle D, et al. Modification of hematopoietic stem cell fate by 5aza 2′ eoxycytidine and trichostatin A. Blood. 2004; 103(11):4102-4110. (Pubitemid 38685350)
23. Araki H, Mahmud N, Milhem M, et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol. 2006;34(2):140-149. (Pubitemid 43184319)
24. Araki H, Yoshinaga K, Boccuni P, Zhao Y, Hoffman R, Mahmud N. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood. 2007;109(8): 3570-3578. (Pubitemid 46572552)
25. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26(11):1269-1275.
26. Gul H, Marquez-Curtis LA, Jahroudi N, Lo J, Turner AR, Janowska-Wieczorek A. Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling. Stem Cells Dev. 2009;18(6):831-838.
27. Obier N, Uhlemann CF, Muller AM. Inhibition of histone deacetylases by trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival. Cytotherapy. 2010;12(7):899-908.
28. Wang X, LeBlanc A, Gruenstein S, et al. Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms. Exp Hematol. 2009;37(10):1194-1200.
29. Dahl JA, Collas P. A rapid micro chromatin immunoprecipitation assay (microChIP). Nat Protoc. 2008;3(6):1032-1045. (Pubitemid 351818692)
30. Blau CA, Barbas CF 3rd, Bomhoff AL, et al. {gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic mice. J Biol Chem. 2005;280(44): 36642-36647. (Pubitemid 41587741)
31. Araki H, Baluchamy S, Petro B, et al. Valproic acid results in maintenance but not expansion of transplantable hematopoietic stem cells from human umbilical cord blood [abstract]. Blood (ASH Annual Meeting Abstracts). 2010;116(22):Abstract 827.
32. Broske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009;41(11):1207-1215.
33. Wozniak RJ, Bresnick EH. Epigenetic control of complex loci during erythropoiesis. Curr Top Dev Biol. 2008;82:55-83.
34. Trowbridge JJ, Snow JW, Kim J, Orkin SH. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell. 2009;5(4):442-449.
35. Kim SI, Bresnick EH. Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene. 2007;26(47):6777-6794. (Pubitemid 47585102)
36. Perry C, Soreq H. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multidomain elements. Eur J Biochem. 2002;269(15): 3607-3618. (Pubitemid 34989109)
37. Pan X, Ohneda O, Ohneda K, et al. Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors. J Biol Chem. 2005;280(23):22385-22394. (Pubitemid 40827894)
38. Lohmann F, Bieker JJ. Activation of Eklf expression during hematopoiesis by Gata2 and Smad5 prior to erythroid commitment. Development. 2008;135(12):2071-2082. (Pubitemid 352022521)
39. + erythroid progenitors: temporal changes in gene and protein expression. Exp Hematol. 2003;31(11):760-769.
40. Georgiou KR, Foster BK, Xian CJ. Damage and recovery of the bone marrow microenvironment induced by cancer chemotherapy-potential regulatory role of chemokine CXCL12/receptor CXCR4 signalling. Curr Mol Med. 2010;10(5): 440-453.
41. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201(8): 1307-1318. (Pubitemid 40629073)
42. van der Loo JC, Xiao X, McMillin D, Hashino K, Kato I, Williams DA. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest. 1998;102(5):1051-1061. (Pubitemid 28419251)
43. Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood. 1993;81(1): 112-121. (Pubitemid 23013684)
44. Milutinovic S, D'Alessio AC, Detich N, Szyf M. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis. 2007;28(3):560-571. (Pubitemid 46523352)
45. Garcia BA, Hake SB, Diaz RL, et al. Organismal differences in posttranslational modifications in histones H3 and H4. J Biol Chem. 2007;282(10): 7641-7655. (Pubitemid 47093632)